Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2017 16:33 ET | Source: Dyadic International, Inc.

Dyadic International Announces the Purchase of 2.36 Million Shares of Its Common Stock From Pinnacle

JUPITER, Fla., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging the...
December 08, 2016 10:23 ET | Source: Dyadic International, Inc.

Dyadic International Shareholders Approve Reverse Stock Split

JUPITER, Fla., Dec. 08, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging the...
November 10, 2016 16:30 ET | Source: Dyadic International, Inc.

Dyadic International Reports Third Quarter 2016 Financial Results

JUPITER, Fla., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging the patented and...
October 27, 2016 16:30 ET | Source: Dyadic International, Inc.

Dyadic International to Announce Third Quarter 2016 Financial Results and Host Conference Call on Thursday, November 10, 2016

JUPITER, Fla., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company announced today that it will report its financial results for...
October 26, 2016 16:30 ET | Source: Dyadic International, Inc.

Dyadic to Seek Shareholder Approval of Reverse Stock Split

Special meeting to be held December 7, 2016 to seek shareholder approvalProxy statement filed with the OTC Markets and posted on Dyadic’s website JUPITER, Fla., Oct. 26, 2016 (GLOBE NEWSWIRE) --...
September 07, 2016 08:30 ET | Source: Dyadic International, Inc.

Dyadic International, Inc. Announces Research and Development Agreement to Further Advance Its Proprietary C1 Fungal Strain for Biopharmaceutical Development & Production

JUPITER, Fla., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the development and large scale manufacture of low...
August 16, 2016 11:11 ET | Source: Dyadic International, Inc.

Dyadic International, Inc. Appoints Arindam Bose, Ph.D., Distinguished Life Sciences Executive, to Board of Directors

JUPITER, Fla., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the development and large scale manufacture of low...
August 11, 2016 16:15 ET | Source: Dyadic International, Inc.

Dyadic International Reports Second Quarter 2016 Financial Results

JUPITER, Fla., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focusing on further improving and leveraging the patented and...
August 11, 2016 14:51 ET | Source: Dyadic International, Inc.

Dyadic International Board Approves a Reverse Stock Split Subject to Obtaining Shareholder Approval

JUPITER, Fla., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company") (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging the...
August 08, 2016 08:30 ET | Source: Dyadic International, Inc.

Dyadic International Reports the Termination of Agreement With Sanofi Pasteur

JUPITER, Fla., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI) announced today the termination of its Proof of Concept, Exclusive Option & Technology...